Stories

This week’s research roundup features a study on protocadherin 7-associated membranous nephropathy.

Top highlights include: Mayo Clinic's response to the Johnson & Johnson COVID-19 vaccine pause, sexually transmitted infections, and should pregnant women be vaccinated for COVID-19?

Dr. Dollahite received world-class cancer treatment from a web of health care organizations, including Mayo Clinic in Rochester, Minnesota. Yet she never left New York; most of her treatment occurred in Ithaca. What made that possible was Cayuga Medical Center’s collaborative relationship with Mayo Clinic. Genetic testing at Mayo Clinic Laboratories provided important information about Dr. Dollahite’s cancer.

For community health care providers, owning a laboratory has been likened to shoveling money down a giant drain. Cayuga Medical Center is challenging that narrative. Instead of selling, Cayuga is investing in its lab — which it considers a value center as well as a key part of patient service.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss vaccine passports. They review how proof of vaccination could be used along with other tools, like testing, to help curb the spread of COVID-19.

Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from them.

This week’s research roundup features a study on noncanonical AR addiction that drives enzalutamide resistance in prostate cancer.

Top highlights include: Lessons learned in addressing global health equity, updates on traveling during the pandemic, and optimism along with concerns about the fourth wave of infections.

Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.

Angela Reese Davis supervises more than 300 staff members in Mayo Clinic Laboratories Specimen Operations. As COVID-19 has brought constant change to her area throughout the last year, Angela and her team have met every challenge with determination, teamwork and grace.

This week’s research roundup features a study on convalescent plasma antibody levels and the risk of death from Covid-19.

Top highlights include: The latest on COVID-19 vaccines for children, youth sport guidelines, and why you should get the first COVID-19 vaccine offered to you.

This week’s research roundup features a study on how a noncanonical AR addiction drives enzalutamide resistance in prostate cancer.